Home › NDC Lookup › RxCUI directory › RxCUI 897712

Hydromorphone hydrochloride 8 MG Oral Tablet [Dilaudid] — RxCUI 897712

RxNorm drug concept · Semantic branded drug
RxCUI 897712 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI897712
Official nameHydromorphone hydrochloride 8 MG Oral Tablet [Dilaudid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDilaudid 8 MG Oral Tablet
FDA products mapped4
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydromorphone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Hydromorphone injection is used to treat severe pain when other pain medicines haven't worked well enough. It's an opioid — a strong prescription pain reliever — and it's typically...
  • What is hydromorphone injection used for?
  • Common side effects include dizziness, drowsiness, nausea, vomiting, itching, sweating, dry mouth, and constipation — these are typical with opioids. But if your breathing feels ve...
  • What side effects should I expect, and which ones mean I need to call for help right away?
📖 Read our full Hydromorphone Injection guide →

🕸️ Concept Web — How Hydromorphone hydrochloride 8 MG Oral Tablet [Di... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydromorphone hydrochloride 8 MG Oral Tablet [Dilaudid] RxCUI 897712

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydromorphone 3423
    • Hydromorphone hydrochloride 203177
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dilaudid 224913
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydromorphone Oral Tablet 370654
    • Hydromorphone hydrochloride Oral Tablet 2648247
    • Hydromorphone Oral Product 1164620
    • Hydromorphone Pill 1164621
    • Hydromorphone hydrochloride Oral Product 2659874
    • Hydromorphone hydrochloride Pill 2661455
    • Hydromorphone Oral Tablet [Dilaudid] 368895
    • Hydromorphone hydrochloride Oral Tablet [Dilaudid] 2656942
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydromorphone hydrochloride 8 MG Oral Tablet SCD · 897710
  • Hydromorphone hydrochloride 8 MG SCDC · 897709
  • Hydromorphone Oral Tablet SCDF · 370654
  • Hydromorphone hydrochloride Oral Tablet SCDFP · 2648247
  • Hydromorphone Oral Product SCDG · 1164620
  • Hydromorphone Pill SCDG · 1164621
  • Hydromorphone hydrochloride Oral Product SCDGP · 2659874
  • Hydromorphone hydrochloride Pill SCDGP · 2661455

Brand-Name Concepts

  • Hydromorphone hydrochloride 8 MG [Dilaudid] SBDC · 897711
  • Hydromorphone Oral Tablet [Dilaudid] SBDF · 368895
  • Hydromorphone hydrochloride Oral Tablet [Dilaudid] SBDFP · 2656942
  • Dilaudid Oral Product SBDG · 1168870
  • Dilaudid Pill SBDG · 1168871
  • Dilaudid BN · 224913

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 897712 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42858-0122-01 100 TABLET in 1 BOTTLE, PLASTIC (42858-122-01) Dilaudid Rhodes Pharmaceuticals LLC 2017-05-15
42858-0234-01 100 TABLET in 1 BOTTLE, PLASTIC (42858-234-01) Dilaudid Rhodes Pharmaceuticals LLC 2017-05-15
42858-0234-50 500 TABLET in 1 BOTTLE, PLASTIC (42858-234-50) Dilaudid Rhodes Pharmaceuticals LLC 2017-05-15
42858-0338-01 100 TABLET in 1 BOTTLE, PLASTIC (42858-338-01) Dilaudid Rhodes Pharmaceuticals LLC 2017-05-15
42858-0416-16 473 mL in 1 BOTTLE, PLASTIC (42858-416-16) Dilaudid Rhodes Pharmaceuticals LLC 2017-05-15
Observed labelers: Rhodes Pharmaceuticals LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.